These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 22049516)

  • 1. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
    Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release.
    Golan K; Vagima Y; Ludin A; Itkin T; Cohen-Gur S; Kalinkovich A; Kollet O; Kim C; Schajnovitz A; Ovadya Y; Lapid K; Shivtiel S; Morris AJ; Ratajczak MZ; Lapidot T
    Blood; 2012 Mar; 119(11):2478-88. PubMed ID: 22279055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex.
    Ratajczak MZ; Lee H; Wysoczynski M; Wan W; Marlicz W; Laughlin MJ; Kucia M; Janowska-Wieczorek A; Ratajczak J
    Leukemia; 2010 May; 24(5):976-85. PubMed ID: 20357827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.
    Forristal CE; Nowlan B; Jacobsen RN; Barbier V; Walkinshaw G; Walkley CR; Winkler IG; Levesque JP
    Leukemia; 2015 Jun; 29(6):1366-78. PubMed ID: 25578474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction.
    Karapetyan AV; Klyachkin YM; Selim S; Sunkara M; Ziada KM; Cohen DA; Zuba-Surma EK; Ratajczak J; Smyth SS; Ratajczak MZ; Morris AJ; Abdel-Latif A
    Stem Cells Dev; 2013 Jun; 22(11):1645-56. PubMed ID: 23282236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
    Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ
    Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing.
    Ryser MF; Ugarte F; Lehmann R; Bornhäuser M; Brenner S
    Mol Immunol; 2008 Nov; 46(1):166-71. PubMed ID: 18760838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    King A; Houlihan DD; Kavanagh D; Haldar D; Luu N; Owen A; Suresh S; Than NN; Reynolds G; Penny J; Sumption H; Ramachandran P; Henderson NC; Kalia N; Frampton J; Adams DH; Newsome PN
    Gastroenterology; 2017 Jul; 153(1):233-248.e16. PubMed ID: 28363640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow.
    Mierzejewska K; Klyachkin YM; Ratajczak J; Abdel-Latif A; Kucia M; Ratajczak MZ
    Biomed Res Int; 2013; 2013():814549. PubMed ID: 24490172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-Phosphate Receptor-3 Supports Hematopoietic Stem and Progenitor Cell Residence Within the Bone Marrow Niche.
    Ogle ME; Olingy CE; Awojoodu AO; Das A; Ortiz RA; Cheung HY; Botchwey EA
    Stem Cells; 2017 Apr; 35(4):1040-1052. PubMed ID: 28026131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy is required for stem cell mobilization by G-CSF.
    Leveque-El Mouttie L; Vu T; Lineburg KE; Kuns RD; Bagger FO; Teal BE; Lor M; Boyle GM; Bruedigam C; Mintern JD; Hill GR; MacDonald KP; Lane SW
    Blood; 2015 May; 125(19):2933-6. PubMed ID: 25788702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBSCs Sphingoling along S1P/S1P1 axis.
    Christopherson KW
    Blood; 2012 Jan; 119(3):645-6. PubMed ID: 22262738
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
    De Clercq E
    Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.
    Winkler IG; Pettit AR; Raggatt LJ; Jacobsen RN; Forristal CE; Barbier V; Nowlan B; Cisterne A; Bendall LJ; Sims NA; Lévesque JP
    Leukemia; 2012 Jul; 26(7):1594-601. PubMed ID: 22266913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
    Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
    Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells.
    Bendall LJ; Basnett J
    Curr Opin Hematol; 2013 Jul; 20(4):281-8. PubMed ID: 23507960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
    Welschinger R; Liedtke F; Basnett J; Dela Pena A; Juarez JG; Bradstock KF; Bendall LJ
    Exp Hematol; 2013 Mar; 41(3):293-302.e1. PubMed ID: 23178377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.